The Effects of Ectoin® Allergy Nasal Spray and Ectoin® Allergy Eye Drops Compared to Placebo

Exclusion criteria

• ✕. Asthma based on medical history or investigator judgment (stable mild asthmatics may be included).
• ✕. Current smoker and ex-smokers with more than 10 pack years smoking history. One pack year is defined as 20 cigarettes/day for 1 year. Smoking must have been stopped more than 6 months ago
• ✕. History of lower or upper airway infection in the last four weeks prior to screening.
• ✕. Clinically significant physical findings of nasal anatomical deformities causing greater than 50% obstruction based on the clinical estimate of the investigator, including nasal polyps, septal defects or other clinically significant respiratory tract malformations, nasal piercing, recent nasal biopsy, nasal trauma, or surgery and atrophic rhinitis or rhinitis medicamentosa within 60 days prior to the Screening Visit.
• ✕. Pregnancy or breastfeeding, or plans to become pregnant or donate gametes (ova or sperm) for in vitro fertilization during the study period, or for 30 days following the study period.
• ✕. Currently participating in a clinical trial or has been exposed to an investigational treatment within the 30 days prior to the Screening Visit.
• ✕. A known or suspected hypersensitivity, and/or contraindication to any of the ingredients of the investigational products.
• ✕. History of alcohol or drug abuse, as judged by the investigator, within the two years prior to the Screening Visit.